Vitae Pharmaceuticals Inc. (VTAE) Vaulted To A New High After Merger

Vitae Pharmaceuticals Inc. (VTAE) announced Tuesday morning that it has agreed to be acquired by Allergan (AGN) for $21.00 per share in cash, approximately $639 million.

from RTT - Before the Bell http://ift.tt/2ctmTJt
via IFTTT